asthma, treatment resistance
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2004 Oct 23;364(9444):1505-12 Randomized Controlled Trial, Multicenter Study
IN asthma, treatment resistance The Use of
a genetic polymorphism of the beta2-adrenergic receptor (Arg/Arg homocygote at residue 16)
As Prognostic Item
Is useful Than
-
To induce resistence to or inversion of the bronchodilator effects of inhaled beta-2 agonists.